These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3030991)

  • 1. 6-(E)-acetylmethylenepenicillanic acid, a potent beta-lactamase inhibitor.
    Adam S; Then RL; Angehrn P
    J Antibiot (Tokyo); 1987 Jan; 40(1):108-9. PubMed ID: 3030991
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential prodrugs of 6-acetylmethylenepenicillanic acid (Ro 15-1903).
    Adam S; Then R; Angehrn P
    J Antibiot (Tokyo); 1986 Jun; 39(6):833-8. PubMed ID: 3015853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
    Angehrn P; Arisawa M
    J Antibiot (Tokyo); 1982 Nov; 35(11):1584-9. PubMed ID: 6298168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.
    Moore BA; Brammer KW
    Antimicrob Agents Chemother; 1981 Sep; 20(3):327-31. PubMed ID: 6272628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene (2S,5R)-6-(3-formylallylidene)penicillanate pivalate, a prodrug of a new beta-lactamase inhibitor.
    Adam S; Then R; Angehrn P
    J Antibiot (Tokyo); 1992 Apr; 45(4):587-8. PubMed ID: 1317369
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitors.
    Wise R; Andrews JM; Patel N
    J Antimicrob Chemother; 1981 May; 7(5):531-6. PubMed ID: 6267005
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
    Li JT; Moosdeen F; Williams JD
    J Antimicrob Chemother; 1982 Apr; 9(4):287-96. PubMed ID: 6282800
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.
    Greenwood D; Eley A
    J Antimicrob Chemother; 1982 Aug; 10(2):117-23. PubMed ID: 6288651
    [No Abstract]   [Full Text] [Related]  

  • 9. In-vitro susceptibility of beta-lactamase-producing Haemophilus influenzae to the combinations ampicillin with mecillinam and ampicillin and VD2085.
    Piot P; van Dyck E
    J Antimicrob Chemother; 1985 Dec; 16(6):808-9. PubMed ID: 3005221
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
    Chao HP; Ho SW; Luh KT; Hsieh WC
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on penam sulfones. I. Synthesis and beta-lactamase inhibitory activity of 2 beta-alkoxycarbonyl penicillanic acid sulfones.
    Setti EL; Reddy NA; Phillips OA; Czajkowski DP; Atchison K; Atwal H; Micetich RG; Maiti SN; Kunugita C; Hyodo A
    J Antibiot (Tokyo); 1996 Sep; 49(9):944-6. PubMed ID: 8931732
    [No Abstract]   [Full Text] [Related]  

  • 12. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated beta-lactamases.
    Arisawa M; Then RL
    J Antibiot (Tokyo); 1982 Nov; 35(11):1578-83. PubMed ID: 6298167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (6R)-6-(substituted methyl)penicillanic acid sulfones: new potent beta-lactamase inhibitors.
    Adam S; Then R; Angehrn P
    J Antibiot (Tokyo); 1993 Apr; 46(4):641-6. PubMed ID: 8388871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
    Micetich RG; Maiti SN; Spevak P; Hall TW; Yamabe S; Ishida N; Tanaka M; Yamazaki T; Nakai A; Ogawa K
    J Med Chem; 1987 Aug; 30(8):1469-74. PubMed ID: 3039137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
    Sorg TB; Cynamon MH
    J Antimicrob Chemother; 1987 Jan; 19(1):59-64. PubMed ID: 3030999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J; Hupková M; Krcméry V
    Cas Lek Cesk; 1995 Sep; 134(17):558-61. PubMed ID: 7553760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH; Keiding J
    J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (6R,8S)-(2-benzimidazolyl)hydroxymethylpenicillanic acids as potent antibacterial agents and beta-lactamase inhibitors.
    Chen YL; Hedberg K; Guarino K; Retsema JA; Anderson M; Manousos M; Barrett J
    J Antibiot (Tokyo); 1991 Aug; 44(8):870-84. PubMed ID: 1655687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.